LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

LLY

1,015.5

+2.79%↑

JNJ

230.41

+2.69%↑

ABBV

208.54

+0.36%↑

UNH

400.53

+1.04%↑

AZN

187.75

+1.77%↑

Kodu・Aktsiate loetelu・Abbott Laboratories

Search

Abbott Laboratories

Suletud

SektorTervishoid

83.84 -0.56

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

82.61

Max

84.32

Põhinäitajad
By Trading Economics
Sissetulek	-699M 1.1B
Müük	-295M 11B
P/E Sektori keskmine	23.126 51.415
Aktsiakasum	1.15
Dividenditootlus	2.89
Kasumimarginaal	9.647
Töötajad	122,000
EBITDA	-980M 1.8B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+42.55% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.89% 2.34%
Järgmine tulemuste avaldamine	16. juuli 2026
Järgmine dividendimakse kuupäev	15. mai 2026
Järgmine aktsia dividendi kuupäev (ex-date)	14. juuli 2026

Turustatistika
By TradingEconomics
Turukapital	-31B 144B
Eelmine avamishind	84.4
Eelmine sulgemishind	83.84

Uudiste sentiment

By Acuity

48%

52%

155 / 346 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

132.82 / 134.43 Toetus ja vastupanu

Abbott Laboratories Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. apr 2026, 15:13 UTC

Tulu

Suurimad hinnamuutused turgudel

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16. apr 2026, 12:23 UTC

Tulu

Suurimad hinnamuutused turgudel

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22. jaan 2026, 18:36 UTC

Tulu

Suurimad hinnamuutused turgudel

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22. jaan 2026, 13:23 UTC

Tulu

Suurimad hinnamuutused turgudel

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16. apr 2026, 20:23 UTC

Tulu

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16. apr 2026, 16:15 UTC

Tulu

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16. apr 2026, 14:00 UTC

Market Talk

Tulu

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16. apr 2026, 13:59 UTC

Market Talk

Tulu

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16. apr 2026, 12:05 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16. apr 2026, 11:32 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs 1Q Sales $11.16B >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs 1Q Net $1.08B >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs 1Q Adj EPS $1.15 >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16. apr 2026, 11:30 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Abbott Labs 1Q EPS 61c >ABT

11. apr 2026, 00:00 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Big Yachts, Big Bucks -- Barrons.com

23. märts 2026, 12:50 UTC

Omandamised, ülevõtmised, äriostud

Abbott Completes Acquisition Of Exact Sciences >ABT

20. märts 2026, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20. märts 2026, 13:00 UTC

Omandamised, ülevõtmised, äriostud

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28. jaan 2026, 14:48 UTC

Tulu

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23. jaan 2026, 16:59 UTC

Tulu

Correction to Abbott Stock Drops Article on Jan. 22

22. jaan 2026, 20:42 UTC

Tulu

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22. jaan 2026, 16:19 UTC

Tulu

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22. jaan 2026, 15:22 UTC

Tulu

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22. jaan 2026, 14:41 UTC

Kuumad aktsiad

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22. jaan 2026, 14:08 UTC

Market Talk

Tulu

Abbott Posts Disappointing 4Q -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Abbott Laboratories Prognoos

Hinnasiht

By TipRanks

42.55% tõus

12 kuu keskmine prognoos

Keskmine 120.24 USD 42.55%

Kõrge 143 USD

Madal 92 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Abbott Laboratories 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

16

Osta

4

Hoia

0

Müü

Põhineb 20 analüütiku instrumendi Abbott Laboratories aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

132.82 / 134.43Toetus ja vastupanu

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bullish.

Sentiment

By Acuity

155 / 346 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

1,015.5

JNJ

Johnson and Johnson

230.41

ABBV

AbbVie Inc

208.54

UNH

UnitedHealth Group Inc

400.53

AZN

AstraZeneca PLC

187.75

Live chat